Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That’s a compound annual growth rate ...

Merck leads U.S. pharma in 2025, but faces Keytruda patent loss by 2028. Click for my look at MRK stock ahead of its upcoming ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House ...

Carter Worth from Worth Charting said in a latest program on CNBC that Merck & Co Inc (NYSE:MRK) is one of the stocks that ...

Merck and health experts push back against U.S. officials' call to split the MMR vaccine, warning it could delay ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the November 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...